KR880701548A - 레티노이드로 일광 손상된 인체 피부를 치료하는 방법 - Google Patents

레티노이드로 일광 손상된 인체 피부를 치료하는 방법

Info

Publication number
KR880701548A
KR880701548A KR1019880700291A KR880700291A KR880701548A KR 880701548 A KR880701548 A KR 880701548A KR 1019880700291 A KR1019880700291 A KR 1019880700291A KR 880700291 A KR880700291 A KR 880700291A KR 880701548 A KR880701548 A KR 880701548A
Authority
KR
South Korea
Prior art keywords
acid
tetramethyl
skin
retinoid
tetrahydro
Prior art date
Application number
KR1019880700291A
Other languages
English (en)
Other versions
KR950014443B1 (ko
Inventor
엠.클리그만 알버트
Original Assignee
엠.클리그만 알버트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엠.클리그만 알버트 filed Critical 엠.클리그만 알버트
Publication of KR880701548A publication Critical patent/KR880701548A/ko
Application granted granted Critical
Publication of KR950014443B1 publication Critical patent/KR950014443B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2224—Compounds having one or more tin-oxygen linkages
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/407—Oxides of zinc, germanium, cadmium, indium, tin, thallium or bismuth

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

레티노이드로 일광 손상된 인체 피부를 치료하는 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 투여시 경미한 자극을 느낄 정도의 용량 및 조성으로 연화제중 유효량의 레티노이드를 함유하는 조성물을 유지 요법 프로그램에 따라 피부면에 국소 투여하여 피부의 경고성, 패안감 및 탄력성을 충분히 회복하고 유지하도록 함을 특징으로 하여, 일광 손상된 인체 피부에서 고원섬유의 손실, 탄력 섬유의 비정상적 변화, 모세혈관의 변질 및 비정상적 상피 증식을 지연 및 역전시키는 방법.
  2. 제1항에 있어서, 레티노이드를 레티노산, 레티노산 유도체 및 그의 입체 이성체 중에서 선택하는 방법.
  3. 제2항에 있어서, 레티노산, 레티노산 유도체를 13-시스-레티노산, 13-시스-레티노산 유도체 및 그의 이성체 중에서 선택하는 방법.
  4. 제1항에 있어서, 레티노이드를(E)-4-[4-메틸-6-(2,6,6-트리메틸-1-시클로헥센-1-일)-1,3,5-헥사트리엔일]벤조산;4-[(5,6,7,8-테트라하이드로-5,5,8,8-테트라메틸-2-나프탈레닐)에틸레닐]-벤조산;및(E)-4-[2-(5,6,7,8-테트라하이드로-7-하이드록시-5,5,8,8-테트라메틸-2-나프탈레닐-1-프로페닐]벤질 알코올 중에서 선택하는 방법.
  5. 제1항에 있어서, 레티노이드를 13-시스-레티노산;(all-E)-9-(4-메톡시-2,3,6-트리메틸페닐)-3,7-디메틸-2,4,6,8-노나테트라에노산 에틸 에스테르;(all-E)-9-(4-메톡시-2,3,6-트리메틸페닐)-3,7-디메틸-2,4,6,8-노나테트라에노산;N-에틸-9-(2,6-디클로로-4-메톡시-3-메틸페닐)-3,7-디메틸-2,4,6,8-노나테트라엔아미드;(E,E)-9-(2,6-디클로로-4-메톡시-3-메틸페닐)-3,7-디메틸-2,4,6,8-노나텐트라에노산 에틸 에스테르;7,8-디데하이드로레티노산;(E,E)-4-[2-메틸-4-(2,6,6-트리메틸-1-시콜로헥센-1-일)-1,3-부타디에닐]벤조산;(all-E)-3,7-디메틸-(3-티에닐)-2,4,6,8-노나테트라에노산;(E,E,E)-3-메틸-7-(5,6,7,8-테트라하이드로-5,5,8,8-테트라메틸-2-나프탈레닐)-2,4,6-옥타트리에노산;(E)-6-[2-(2,6,6-트리메틸-1-시클로헥센-1-일)에테닐]-2-나프탈렌카복실산;(E,E,E)-7-(2,3-디하이드로-1,1,3,3-테트라메틸-1H-인덴-5-일)-3-메틸-2,4,6-옥타트리에노산;(E)-4-[2-(2,3-디하이드로-1,1,3,3-테트라메틸-1H-인덴-5-일)-1-프로페닐]벤조산;TTNPB(E)-4-[2-(5,6,7,8-테트라하이드로-5,5,8,8-테트라메틸-2-나프탈레닐-1-프로페닐]벤조산;(E)-1,2,3,4-테트하이드로-1,1,4,4-테트라메틸-6-(1-메틸-2-페닐에테닐)나프탈렌;6-(1,2,3,4-테트라하이드로-1,1,4,4-테트라메틸-6-나프틸)-2-나프탈렌 카복실산;(E)-6-[-2[4-(에틸설포닐)페닐]-1-메틸에테닐]-1,2,3,4-테트라하이드로-1,1,4,4-테트라메틸나프탈렌; 및 (E)-2-(1,1,4,4-테트라메틸-1,2,3,4-테트라하이드로나프트-7-일)-1-[4-(테트라졸-5-일)페닐]-1-프로펜 중에서 선택하는 방법.
  6. 제1항에 있어서, 피부가 인체 안면 피부인 방법.
  7. 제2항에 있어서, 피부가 인체 안면 피부인 방법.
  8. 제3항에 있어서, 피부가 인체 안면 피부인 방법.
  9. 제1항에 있어서, 연화제가 크림 연고인 방법.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880700291A 1986-07-16 1987-07-15 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물 KR950014443B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88659586A 1986-07-16 1986-07-16
US886595 1986-07-16
US886,595 1986-07-16
PCT/US1987/001698 WO1988000466A1 (en) 1986-07-16 1987-07-15 Methods for treatment of sundamaged human skin with retinoids

Publications (2)

Publication Number Publication Date
KR880701548A true KR880701548A (ko) 1988-11-03
KR950014443B1 KR950014443B1 (ko) 1995-11-28

Family

ID=25389338

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700291A KR950014443B1 (ko) 1986-07-16 1987-07-15 일광손상된 인체피부를 치료하기 위한 레티노이드를 함유하는 조성물

Country Status (10)

Country Link
EP (1) EP0253393A3 (ko)
JP (1) JP2606711B2 (ko)
KR (1) KR950014443B1 (ko)
AU (1) AU599135B2 (ko)
CA (1) CA1303996C (ko)
DK (1) DK140388A (ko)
FI (1) FI881217A (ko)
NO (1) NO881051L (ko)
NZ (1) NZ221090A (ko)
WO (1) WO1988000466A1 (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440831A1 (de) * 1984-05-16 1986-05-15 A. J. Tröster GmbH & Co KG, 6308 Butzbach Siebband fuer eine hackfrucht-erntemaschine
LU86345A1 (fr) * 1986-03-06 1987-11-11 Oreal Nouveaux derives benzofuranniques,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
WO1988007857A1 (en) * 1987-04-06 1988-10-20 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid
US5075333A (en) * 1987-08-19 1991-12-24 Hoffmann-La Roche Inc. Tetrahydronaphthalene and indane compounds useful for reversing the photo-damage in sun-exposed skin
US5061733A (en) * 1987-08-19 1991-10-29 Hoffmann-La Roche Inc. Tetrahydronaphthalene and indane compounds useful for reversing the photodamage in sun-exposed skin
US5770626A (en) * 1987-08-19 1998-06-23 Hoffmann-La Roche Inc. Tetrahydronaphtalene and indane compounds useful for reversing the photodamage in sun-exposed skin
ZA885192B (en) * 1987-08-19 1989-04-26 Hoffmann La Roche Pharmaceutical preparations
NZ228123A (en) * 1988-02-25 1991-12-23 Beecham Group Plc Topical skin treatment composition comprising at least one ester of retinol
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
WO1990008760A1 (de) * 1989-02-02 1990-08-09 Basf Aktiengesellschaft Verwendung von hexatrienderivaten zur herstellung von mitteln gegen akne, psoriasis und lichtschäden der haut
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2644459B1 (fr) * 1989-03-16 1994-10-28 Oreal Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
CA2035594A1 (en) * 1990-02-12 1991-08-13 Ronald J. Shannon Use of retinoids to minimize skin damage
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
FR2736548B1 (fr) * 1995-07-10 1997-10-03 Fabre Pierre Dermo Cosmetique Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
FR2753091B1 (fr) * 1996-09-09 2001-03-16 Oreal Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6063817A (en) * 1997-02-21 2000-05-16 Bristol-Myers Squibb Company Use of substituted (5,6) dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
MX2018009351A (es) 2016-02-03 2019-01-10 Galderma Res & Dev Nuevos compuestos bioaromaticos de propinilo, composiciones farmaceuticas y cosmeticas que contienen los mismos y usos de los mismos.
MX2020003762A (es) 2017-09-28 2022-05-03 Johnson & Johnson Consumer Inc Composiciones cosmeticas y metodo para tratar la piel.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
DE3440831A1 (de) * 1984-05-16 1986-05-15 A. J. Tröster GmbH & Co KG, 6308 Butzbach Siebband fuer eine hackfrucht-erntemaschine
LU85558A1 (fr) * 1984-09-28 1986-04-03 Oreal Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
LU86022A1 (fr) * 1985-07-25 1987-02-04 Cird Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
JPS62185005A (ja) * 1986-02-10 1987-08-13 アルバ−ト・エム・クリグマン 皮膚の老化作用を抑制する組成物及び方法
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid

Also Published As

Publication number Publication date
NO881051D0 (no) 1988-03-09
EP0253393A2 (en) 1988-01-20
AU7804687A (en) 1988-02-10
JP2606711B2 (ja) 1997-05-07
FI881217A0 (fi) 1988-03-15
NO881051L (no) 1988-03-09
NZ221090A (en) 1990-05-28
JPH01500355A (ja) 1989-02-09
DK140388D0 (da) 1988-03-15
WO1988000466A1 (en) 1988-01-28
CA1303996C (en) 1992-06-23
EP0253393A3 (en) 1988-10-12
KR950014443B1 (ko) 1995-11-28
AU599135B2 (en) 1990-07-12
DK140388A (da) 1988-05-09
FI881217A (fi) 1988-03-15

Similar Documents

Publication Publication Date Title
KR880701548A (ko) 레티노이드로 일광 손상된 인체 피부를 치료하는 방법
US4888342A (en) Methods for treatment of sundamaged human skin with retinoids
US4877805A (en) Methods for treatment of sundamaged human skin with retinoids
KR950700069A (ko) 염증성 피부병의 치료방법(Methods of treating inflammatory dermatoses)
US5051449A (en) Treatment of cellulite with retinoids
Boyd An overview of the retinoids
FI114968B (fi) Kosmeettinen menetelmä luontaisesti vanhenevan ihon oireiden estämiseksi retinoideilla
JPS63152313A (ja) グルココルチコイドで誘発される皮膚萎縮症の防止
US5019569A (en) Reversal of glucocorticoid-induced skin atrophy
USRE36068E (en) Methods for treatment of sundamaged human skin with retinoids
WO1996030009A2 (en) Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
AU629417B2 (en) Methods of preventing and reducing the size of striae distensae lesions
US5470567A (en) Synergistic skin depigmentation composition
IE920623A1 (en) Methods for treatment of scarring fibrotic alopecia
EP0448213A2 (en) The use of retinoids to minimize skin damage
CONS Retinol, Retinyl Esters, and Retinoic Acid
TW201536335A (zh) 脂肪酸於減少與類視色素治療相關之皮膚刺激的用途
e Paolo a fixed combination of hydroxypinacolone retinoate, retinol glycospheres and papain glycospheres

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19991015

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee